MarketScreener Strategies Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 12:04:57 14/04/2026 +03			5-day change	1st Jan Change
246.80 ^DKK	+3.59%		+4.87%	-24.20%

11:34am	Novo Nordisk, Microsoft-backed OpenAI Partner to Accelerate Drug Development With AI Integration	MT
11:10am	Intertek certifies its growth, LVMH loses its luster

MarketScreener Strategies

	Novo Nordisk: Slipping expectations frustrate investors again and again	February 12, 2026 at 09:08 am
	Novo Nordisk: What is Novo really up against?	February 05, 2026 at 08:58 pm
	Novo Nordisk exposed to a price war over obesity treatments	February 04, 2026 at 10:38 pm
	Novo Nordisk: Disappointing the markets is becoming a habit	February 04, 2026 at 04:15 pm
	Novo Nordisk plunges as its 2026 outlook rattles investors	February 04, 2026 at 02:10 pm
	Novo Nordisk steady amid Lilly Retatrutide risks	December 12, 2025 at 07:14 pm
	No plane sailing for Novo Nordisk	November 25, 2025 at 04:20 pm
	Novo Nordisk valuation hit by obesity fears	November 25, 2025 at 12:42 pm
	Novo Nordisk faces US drug price cuts but gains wider obesity coverage	November 10, 2025 at 04:52 pm
	Novo Nordisk faces earnings miss and guidance cut amid obesity drug Competition	November 05, 2025 at 06:16 pm
	Novo Nordisk: Exhibiting aggression, Novo gatecrashes Pfizer-Metsera's party	October 31, 2025 at 05:18 pm
	All hands on deck at Novo Nordisk!	September 10, 2025 at 01:04 pm
	Novo Nordisk: Wegovy - beyond diabetes and obesity	August 19, 2025 at 11:17 am
	Novo Nordisk falters once again	July 29, 2025 at 04:39 pm
	How did Novo Nordisk lose the US market?	July 02, 2025 at 01:11 pm
	The Parvus fund enters Novo Nordisk's capital	June 10, 2025 at 03:06 pm
	Wegovy on the rise amongst American teens; between effectiveness and reluctance	June 04, 2025 at 12:01 pm
	Novo Nordisk CEO ousted as battle against obesity intensifies	May 16, 2025 at 04:40 pm
	MarketScreener roundup: abysmal trade deficit and massive share buybacks in the US; Novo Nordisk's valuation on a diet	May 07, 2025 at 01:06 pm
	Novo Nordisk is weak, but that's enough	May 07, 2025 at 11:27 am
	Novo Nordisk: Penalized by Eli Lilly's success	April 22, 2025 at 03:06 pm
	Novo Nordisk under threat from first anti-obesity generics	March 10, 2025 at 05:37 pm
	Cagrisema sends Novo Nordisk to the mat	December 20, 2024 at 02:20 pm
	Novo Nordisk A/S: Volatility continues unabated	November 07, 2024 at 08:28 pm
	Novo Nordisk doesn't disappoint	January 31, 2024 at 06:48 pm